- Previous Close
177.05 - Open
175.20 - Bid --
- Ask --
- Day's Range
175.20 - 183.25 - 52 Week Range
128.70 - 219.90 - Volume
278,839 - Avg. Volume
351,176 - Market Cap (intraday)
14.68B - Beta (5Y Monthly) --
- PE Ratio (TTM)
29.57 - EPS (TTM)
6.05 - Earnings Date --
- Forward Dividend & Yield 2.50 (1.50%)
- Ex-Dividend Date Nov 28, 2024
- 1y Target Est
240.00
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the name ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; emergency and critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurosciences; pediatrics; neonatology; robotic procedures; bariatric and metabolic surgery; minimally invasive gyanecological surgery; and urology. It also operates clinics and pharmacies, as well as provides academic and diagnostic services, and sale of power. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
ilshospitals.com1,887
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: GPTHEALTH.NS
View MorePerformance Overview: GPTHEALTH.NS
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GPTHEALTH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GPTHEALTH.NS
View MoreValuation Measures
Market Cap
14.68B
Enterprise Value
14.68B
Trailing P/E
29.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.68
Price/Book (mrq)
6.36
Enterprise Value/Revenue
3.68
Enterprise Value/EBITDA
15.82
Financial Highlights
Profitability and Income Statement
Profit Margin
11.89%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
4.02B
Net Income Avi to Common (ttm)
477.54M
Diluted EPS (ttm)
6.05
Balance Sheet and Cash Flow
Total Cash (mrq)
190.31M
Total Debt/Equity (mrq)
13.98%
Levered Free Cash Flow (ttm)
--